CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI)

27 filings reported holding CASI - CASI Pharmaceuticals, Inc. - Ordinary Shares as of Q2 2024.
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 352,170 shares of 20,761,963 outstanding shares and own 1.7% of the company stock.
Largest 10 shareholders include VR Adviser, LLC (111,686 shares), Wellington Shields Capital Management, LLC (89,217 shares), Wellington Shields & Co., LLC (43,091 shares), RENAISSANCE TECHNOLOGIES LLC (40,800 shares), GEODE CAPITAL MANAGEMENT, LLC (22,221 shares), HOWLAND CAPITAL MANAGEMENT LLC (15,072 shares), UBS Group AG (11,321 shares), ADAR1 Capital Management, LLC (8,240 shares), Royal Bank of Canada (6,900 shares), and MORGAN STANLEY (1,440 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.